The SAVING (Sustainable Access and Delivery of New Vaccines in Ghana) consortium led by the University of Health and Allied Sciences is building capacity of multiple stakeholders (Ghana Food and Drugs Authority (FDA), Ministry of Health (MoH) and the Ghana Health Service (GHS)) to identify and address implementation challenges for the efficient and effective delivery and uptake of new medical interventions. The work of the SAVING consortium builds on the framework of the Access and Delivery Partnership value chain, which stresses the importance of an efficient regulatory control system, an enabling policy and regulatory environment, a robust health technology assessment system, an efficient procurement and supply chain management, quality implementation and delivery research and responsive pharmacovigilance system, as key cornerstones for effective delivery of any new medical intervention.
The consortium uses Implementation Research (IR) as the guiding principle for its work and builds technical and IR capacity in partner institutions to facilitate the delivery and uptake of new medical interventions in Ghana. Specifically, the proposed interventions aim at identifying and addressing technical capacity gaps of
national institutions, building institutional and individual capacity in implementation research and enhancing capacities to utilise evidence-based decision-making for effective delivery of new health technologies. To achieve these objectives, the consortium collects data to understand inherent gaps, conducts at least 2 implementation research studies to learn lessons from the deployment of a mobile application and a patient information system. Data generated from these interventions are used to inform the policy revision process at the National level and contribute to knowledge exchange through South-South and North-South partnership. Furthermore lessons learnt and evidence gleaned from the project contribute to the development of a health system that is well equipped, fit for purpose and ready to support the delivery of the new malaria vaccine and other new health technologies.
Swiss TPH leads on Workpackage 5 "Knowledge management and dissemination" which (1) analyses current and future stakeholders positioning in terms of interest, influence and institutional capacity, decorticates stakeholders position in respect to planning and communications, and (2) contributes to research synthesis and evidence synthesis and the set up digital knowledge management processes and system to facilitate access to knowledge by all partners, and (3) produce user-friendly evidence syntheses for stakeholders and, particularly, for the MOH and GHS, and (4) fosters institutional knowledge management.